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Thyroid-specific transcription factor 1 (TTF-1) is a transcription factor encoded by
the NKX2-1 gene. TTF-1 expression is assumed to be restricted to pulmonary and
thyroid epithelium.
However, nuclear staining has been described in colorectal cancer, breast cancer,
cholangiocarcinoma and adenocarcinoma of the cervix and endometrium, amongst
others. This aspecific immunohistochemical staining occurred in both primary
tumours and metastases.
Two commercially available monoclonal anti-TTF-1 antibodies are commonly used:
SPT24 and 8G7G3/1. The SPT24 clone is suspected to be more sensitive but less
specific than the 8G7G3/1 clone.
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Materials & methods
Archived paraffin-embedded tissue blocks were retrieved from
106 DLBCL cases, of which 32 were diagnosed at the St Luc
Hospital (Brussels, Belgium) and 74 were diagnosed at Ghent
University Hospital (Ghent, Belgium).
Immunohistochemistry for TTF-1 was performed on 3,5 µm
tissue sections using an automated immunostainer (Benchmark
XT, Ventana Medical Systems, Oro Valley, AZ, USA). Two anti-
TTF-1 clones were used: the SPT24 clone (dilution 1/20,
NovocastraTM liquid mouse monoclonal antibody, Leica
Biosystems Newcastle Ltd, UK) and the 8G7G3/1-clone (dilution
1/50, mouse monoclonal, Dako Cytomation, Glostrup, Denmark).
Information on germinal center B-cell-like (GCB) and non-GCB
immunohistochemical subgroups based on the Hans algorithm
(immunohistochemistry for CD10, Bcl-6 and MUM1) was
retrieved from histopathological reports and was available for 93
of 106 cases (88%).
Aim of this study
To our knowledge, TTF-1 expression has not yet been described in diffuse large B-
cell lymphoma (DLBCL). We encountered an index case of DLBCL expressing
TTF-1, which prompted us to investigate TTF-1 expression in a series of DLBCL.
A man with a history of pulmonary
adenocarcinoma presented with a
subcutaneous mass on the thoracic wall.
Routine hematoxylin/eosin staining
showed a poorly differentiated large cell
neoplasm.
Initial immunohistochemistry showed a
lesion which was broad spectrum
cytokeratin negative, S100 negative, and
CD45 positive. Although the positivity for
CD45 indicated a lymphoma, this lesion
presented TTF-1/SPT24 expression as
well. Additional staining with the
8G7G3/1 clone for TTF-1 was negative.
Further immunohistochemical analysis
showed a diffuse large B-cell lymphoma,
non-GCB type, with double expression of
c-Myc and Bcl-2 without rearrangement
of MYC and BCL2 genes.
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Immunohistochemical analysis of 105
additional DLBCL cases revealed nuclear
staining for TTF-1/SPT24 in 3 extra DLBCL
cases (Figures C-D). No nuclear staining
for TTF-1/G87G3/1 was observed (Figures
A-B). None of the cases presented with
cytoplasmic positivity for either of the TTF-
1 clones.
In all, this cohort of 106 DLBCL contained
4 cases (3,8%) with nuclear positivity for
TTF-1/SPT4. According to the Hans
algorithm, two of these DLBCL cases
belonged to the germinal center B-cell-like
(GCB) immunohistochemical subgroup
and two were non-GCB type.
Figures A and B show no immunohistochemical
staining for TTF-1 with the 8G7G3/1 clone in 2 DLBCL
cases, whereas figures C and D (same cases) clearly
present nuclear staining with the TTF-1/SPT24 clone.
Both the 8G7G3/1 and
SPT24 clones for TTF-1 are
widely used, but our study
shows that the SPT24 clone
might result in false positive
TTF-1 expression in 3,8% of
DLBCL. Although this is a
rather rare phenomenon, it
could present an important
diagnostic pitfall during the
investigation of a poorly
differentiated malignancy.
To increase awareness, we
recommend that this
phenomenon should be
included in the datasheet of
the NovocastraTM liquid
mouse monoclonal SPT24
antibody (Leica Biosystems
Newcastle, UK).
